 Regulus Therapeutics, Inc. NASDAQ:RGLS Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET Company Participants Crispina Calsada - CFO Joseph Hagan - President CEO Conference Call Participants Yi Chen - H.C. Wainwright Co. Operator Good morning, and welcome to the Regulus Therapeutics Second Quarter Financial Results Conference Call. 